⌘K

Login Start Free

Home/Filings/4/0001290739-04-000002

4//SEC Filing

MARCEL GEORGES ANTHONY 4

Accession 0001290739-04-000002

CIK 0000713275other

View on SEC.gov Company Profile

Filed

May 26, 8:00 PM ET

Accepted

May 27, 3:47 PM ET

Size

35.0 KB

Accession

0001290739-04-000002

Insider Transaction Report

Form 4

Period: 2004-05-25

PHARMOS CORPPARS

MARCEL GEORGES ANTHONY

Director

Transactions

Exercise/Conversion
Common Stock
2004-05-25$1.25/sh+7,500$9,375→ 18,750 total
Sale
Common Stock
2004-05-25$3.40/sh−13,905$47,277→ 36,095 total
Exercise/Conversion
Stock Options
2004-05-25−11,250→ 3,750 total
Exercise: $1.75From: 2002-09-17Exp: 2008-09-17→ Common Stock (11,250 underlying)
Sale
Common Stock
2004-05-25$3.42/sh−5,000$17,100→ 0 total
Exercise/Conversion
Common Stock
2004-05-25$1.90/sh+10,000$19,000→ 43,750 total
Exercise/Conversion
Common Stock
2004-05-25$1.02/sh+6,250$6,375→ 50,000 total
Sale
Common Stock
2004-05-25$3.32/sh−5,795$19,239→ 6,895 total
Exercise/Conversion
Stock Options
2004-05-25−10,000→ 10,000 total
Exercise: $1.90Exp: 2012-03-05→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2004-05-25$1.75/sh+11,250$19,688→ 11,250 total
Sale
Common Stock
2004-05-25$3.37/sh−3,064$10,326→ 27,393 total
Exercise/Conversion
Stock Options
2004-05-25−6,250→ 13,750 total
Exercise: $1.02Exp: 2013-02-18→ Common Stock (6,250 underlying)
Sale
Common Stock
2004-05-25$3.36/sh−1,500$5,040→ 25,893 total
Exercise/Conversion
Stock Options
2004-05-25−15,000→ 5,000 total
Exercise: $1.88Exp: 2011-04-02→ Common Stock (15,000 underlying)
Sale
Common Stock
2004-05-25$3.35/sh−6,305$21,122→ 19,588 total
Sale
Common Stock
2004-05-25$3.33/sh−6,898$22,970→ 12,690 total
Sale
Common Stock
2004-05-25$3.38/sh−1,895$6,405→ 5,000 total
Exercise/Conversion
Stock Options
2004-05-25−7,500→ 2,500 total
Exercise: $1.25From: 2003-04-16Exp: 2009-04-16→ Common Stock (7,500 underlying)
Exercise/Conversion
Common Stock
2004-05-25$1.88/sh+15,000$28,125→ 33,750 total
Sale
Common Stock
2004-05-25$3.39/sh−5,638$19,113→ 30,457 total

Footnotes (3)

[F1]15,000 options were exercisable as of 4/2/2004. 5,000 options become exercisable on 4/2/2005.
[F2]10,000 options were exercisable as of 3/5/2004. 10,000 options become exercisable in eight equal quarterly increments between 6/5/2004 and 3/5/2006.
[F3]6,250 options were exercisable as of 5/18/2004. 13,750 options become exercisable in eleven equal quarterly increments between 8/18/2004 and 2/18/2007.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

PHARMOS CORP

CIK 0000713275

Entity typeother

Related Parties

1

filerCIK 0001212645

Filing Metadata

Form type: 4
Filed: May 26, 8:00 PM ET
Accepted: May 27, 3:47 PM ET
Size: 35.0 KB

View on SEC.gov